-
Something wrong with this record ?
WWOX, a new potential tumor suppressor gene
R. Hezova, J. Ehrmann, Z. Kolar
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
Grant support
1A8244
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
17690733
DOI
10.5507/bp.2007.002
Knihovny.cz E-resources
- MeSH
- Gene Expression MeSH
- Humans MeSH
- Tumor Suppressor Proteins genetics MeSH
- Prostatic Neoplasms genetics MeSH
- Breast Neoplasms genetics MeSH
- Ovarian Neoplasms genetics MeSH
- Neoplasms genetics MeSH
- Oxidoreductases genetics MeSH
- Genes, Tumor Suppressor MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND: WWOX (WW domain-containing oxidoreductase) gene, located on chromosome 16q 23.3-24.1 in the region recognized as the common fragile site FRA16D is considered to be a tumor suppressor gene involved in various cancers: breast, ovarian, prostate, esophageal, lung, pancreatic, gastric and hepatic. The aim of this study was to describe (i) putative protein interactions of WWOX (ii) the molecular mechanisms of tumor suppressor activity (iii) present an overview of WWOX in relation to nervous system and breast, prostate and ovarian cancers. METHODS AND RESULTS: WWOX expression is up-regulated in endocrine organs indicating its importance in these tissues. In many cancers WWOX expression is down-regulated and low WWOX expression is related to poor prognosis. CONCLUSION: All the evidence suggest that WWOX can be considered as a new tumor suppressor gene and target for gene therapy due to the association of high WWOX expression with improved disease free survival.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003647
- 003
- CZ-PrNML
- 005
- 20130814075825.0
- 007
- ta
- 008
- 130128s2007 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2007.002 $2 doi
- 035 __
- $a (PubMed)17690733
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Héžová, Renata $7 xx0157096 $u Department of Pathology & Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc
- 245 10
- $a WWOX, a new potential tumor suppressor gene / $c R. Hezova, J. Ehrmann, Z. Kolar
- 520 9_
- $a BACKGROUND: WWOX (WW domain-containing oxidoreductase) gene, located on chromosome 16q 23.3-24.1 in the region recognized as the common fragile site FRA16D is considered to be a tumor suppressor gene involved in various cancers: breast, ovarian, prostate, esophageal, lung, pancreatic, gastric and hepatic. The aim of this study was to describe (i) putative protein interactions of WWOX (ii) the molecular mechanisms of tumor suppressor activity (iii) present an overview of WWOX in relation to nervous system and breast, prostate and ovarian cancers. METHODS AND RESULTS: WWOX expression is up-regulated in endocrine organs indicating its importance in these tissues. In many cancers WWOX expression is down-regulated and low WWOX expression is related to poor prognosis. CONCLUSION: All the evidence suggest that WWOX can be considered as a new tumor suppressor gene and target for gene therapy due to the association of high WWOX expression with improved disease free survival.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádory prsu $x genetika $7 D001943
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a exprese genu $7 D015870
- 650 _2
- $a tumor supresorové geny $7 D016147
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a nádory $x genetika $7 D009369
- 650 _2
- $a nádory vaječníků $x genetika $7 D010051
- 650 _2
- $a oxidoreduktasy $x genetika $7 D010088
- 650 _2
- $a nádory prostaty $x genetika $7 D011471
- 650 _2
- $a nádorové supresorové proteiny $x genetika $7 D025521
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ehrmann, Jiří, $d 1967- $7 jo2003163162 $u Department of Pathology & Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc
- 700 1_
- $a Kolář, Zdeněk, $d 1953- $7 jn20000710256 $u Department of Pathology & Laboratory of Molecular Pathology, Faculty of Medicine and Dentistry, Palacky University, Olomouc
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 151, č. 1 (2007), s. 11-15
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130814080334 $b ABA008
- 999 __
- $a ok $b bmc $g 966303 $s 801842
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2007 $b 151 $c 1 $d 11-15 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- GRA __
- $a 1A8244 $p MZ0
- LZP __
- $b NLK111 $a Pubmed-20130128